Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro
Endocrine · 19.02.2024 · 84 (3) · 1238-1249
DOI: 10.1007/s12020-024-03726-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 19.02.2024. Verfasst von Renjiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Educati…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Oxidative Stress, Testosterone, Lipoproteins, LDL. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: To determine the relationship between serum total testosterone (TT) levels and oxidative stress indices in patients with polycystic ovary syndrome (PCOS), and to investigate the effect of oxidative stress on androgen synthesis and its mechanism in rat ovarian theca-interstitial (T-I) cells. METHODS: Clinical, hormonal, metabolic, and oxidative stress parameters were analyzed in a cross-sectional case-control study including 626 patients with PCOS and 296 controls. The effects of oxidized low-density lipoprotein (ox-LDL) and oxidized high-density lipoprotein (ox-HDL) on cell proliferation, TT secretion, and expression of key enzymes involved in testosterone synthesis were evaluated in T-I cells. RESULTS: Serum TT levels were elevated with an increase in ox-LDL levels, whereas glutathione concentrations were lower in the high-TT subgroup than in the low-TT subgroup. The average ovarian volume and ox-LDL and malondialdehyde levels were significant predictors of TT levels in the multivariate regression models. In a rat ovarian T-I cell model, lipoprotein and oxidized lipoprotein treatments stimulated proliferation and promoted testosterone secretion. The mRNA and protein levels of 17α-hydroxylase were significantly higher in oxidized lipoprotein-treated cells than those in lipoprotein-treated cells. The mRNA levels of cholesterol side chain cleavage enzyme and steroidogenic acute regulatory protein were also significantly higher in ox-HDL-treated cells than in HDL-treated cells. CONCLUSIONS: Oxidative stress can promote androgen production by up-regulating the expression of testosterone synthesis-related enzymes in vitro and may be an essential factor in elevating serum TT levels in patients with PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu…
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Ping Fan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, R., Hu, K., Bai, H., Liu, H., Pu, Y., Yang, C., Liu, Q., & Fan, P. (2024). Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro. Endocrine, 84(3), 1238-1249. https://doi.org/10.1007/s12020-024-03726-2
Vancouver
Zhang R, Hu K, Bai H, Liu H, Pu Y, Yang C, et al. Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro. Endocrine. 2024;84(3):1238-1249. doi:10.1007/s12020-024-03726-2
BibTeX
@article{Zhang2024,
author = {Zhang, Renjiao and Hu, Kaifeng and Bai, Huai and Liu, Hongwei and Pu, Yifu and Yang, Chunyi and Liu, Qingqing and Fan, Ping},
title = {Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro},
journal = {Endocrine},
year = {2024},
volume = {84},
number = {3},
pages = {1238--1249},
doi = {10.1007/s12020-024-03726-2}
}
EUVIMED